Male breast cancer in Tripoli, Libya

Saudi Medical Journal

Volumn 30, Issue 8, 2009, Pages 1060-1062

  El Habbash, Manal M ^a,b   Alwindi, Abukris A ^a  

^a Tripoli Medical Centre   (Libyan Arab Jamahiriya)

^b UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; ARTICLE; AXILLARY CLEARANCE; BREAST BIOPSY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LIBYAN ARAB JAMAHIRIYA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MALE BREAST; MASTECTOMY; MULTIPLE MYELOMA; OVERALL SURVIVAL; PARTIAL MASTECTOMY; SURVIVAL RATE;

BREAST NEOPLASMS, MALE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIBYA; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES;

EID: 70349498666     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Czene K, Bergqvist J, Hall P, Bergh J. How to treat male breast cancer. Breast 2007; 16 (Suppl 2): S147-S154.
2. Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 2004; 83: 77-86.
3. Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: A review of 229 patients who presented to the Princess Margaret Hospital during 40 years; 1955-1996. Cancer 1999; 85: 629-639.
4. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006; 367: 595-604.
5. Satram-Hoang S, Ziogas A, Anton-Culver H. Risk of second primary cancer in men with breast cancer. Breast Cancer Res 2007; 9: R10.
6. Auvinen A, Curtis RE, Ron E. Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 2002; 94: 1330-1332.
7. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Volume 7. Lyon (France): IARC Scientific Publication; 1997.
8. Lenfant-Pejovic MH, Mlika-Cabanne N, Bouchardy C, Auquier A. Risk factors for male breast cancer: A Franco-Swiss case-control study. Int J Cancer 1990; 45: 661-665.
9. Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, et al. Breast cancer in men: Aspects of familial aggregation. J Natl Cancer Inst 1991; 83: 849-854.
10. Cuzick J. Epidemiology of breast cancer-selected highlights. Breast 2003; 12: 405-411.
11. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002; 137: 678-687.
12. Thomas DB, Jimenez LM, McTiernan A, Rosenblatt K, Stalsberg H, Stemhagen A, et al. Breast cancer in men: Risk factors with hormonal implications. Am J Epidemiol 1992; 135: 734-748.
13. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993; 53: 538-549.
14. El Habbash M, Alwindi A. Survival of Breast Cancer Patients Treated in Tripoli/Libya. 2000-2005 St Gallen International Breast Cancer conference in Switzerland 2007 poster 156 (The Breast suppl.Vol.16), Jamahiriya Medical Journal 2009; 9: 144-147.
15. Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother 2007; 8: 193-202.
16. Giordano SH, Hortobagyi GN. Leuprolide acetate plus aromatase inhibition for male breast cancer. J Clin Oncol 2006; 24: 42-43.
17. Vaz FH, Opinião AS, Rodrigues PC, Machado PM, Fragaso S, Santos S, et al. Men attending a breast cancer risk evaluation clinic. 31st Annual San Antonio Breast Cancer Symposium December 2008. abstract 1103 page 135. Available from URL: Http://www.sabcs.org.